Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings

Athan, E; O'Brien, DP; Legood, R; (2010) Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings. AIDS (London, England), 24 (12). pp. 1887-1895. ISSN 0269-9370 DOI: https://doi.org/10.1097/QAD.0b013e32833b25ed

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1097/QAD.0b013e32833b25ed

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar